Patient burden of moderate to severe atopic dermatitis
Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2 b clinical trial of dupilumab in adults Eric L. Simpson, MD, MCR, Thomas Bieber, MD, Laurent Eckert, Ph. D, Richard Wu, Ph. D, Marius Ardeleanu, MD, Neil M. H. Graham, MD, Gianluca Pirozzi, MD, Ph. D, Vera Mastey, MSc Journal of the American Academy of Dermatology Volume 74 Issue 3 Pages 491 -498 (March 2016) DOI: 10. 1016/j. jaad. 2015. 10. 043 Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Journal of the American Academy of Dermatology 2016 74491 -498 DOI: (10. 1016/j. jaad. 2015. 10. 043) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 Journal of the American Academy of Dermatology 2016 74491 -498 DOI: (10. 1016/j. jaad. 2015. 10. 043) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions
Fig 3 Journal of the American Academy of Dermatology 2016 74491 -498 DOI: (10. 1016/j. jaad. 2015. 10. 043) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions
Fig 4 Journal of the American Academy of Dermatology 2016 74491 -498 DOI: (10. 1016/j. jaad. 2015. 10. 043) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions
- Slides: 5